Mortality and long-term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: A retrospective study

Clinical and Experimental Rheumatology

Volumn 30, Issue 3, 2012, Pages 338-344

  Anton J M ^a   Castro, P ^a   Espinosa, G ^a   Marcos, M ^a   Gandia M ^a   Merchan R ^a   Cervera, R ^a   Nicolas J M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiphospholipid syndrome; Autoimmune diseases; Intensive care units; Mortality; Systemic lupus erythematosus; Vasculitis

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; PARACETAMOL;

ADULT; AGE; ANAPHYLAXIS; ANTIPHOSPHOLIPID SYNDROME; APACHE; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DERMATOMYOSITIS; DESCRIPTIVE RESEARCH; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; INFECTION; INTENSIVE CARE; LENGTH OF STAY; LIVER TOXICITY; LONG TERM SURVIVAL; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SJOEGREN SYNDROME; SPAIN; SURVIVAL RATE; SYSTEMIC AUTOIMMUNE DISEASE; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS; TERTIARY HEALTH CARE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASES; DERMATOMYOSITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; SURVIVORS; VASCULITIS;

EID: 84864757322     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ANSELL SM, BEDHESI S, RUFF B et al. Study of critically ill patients with systemic lupus erythematosus. Crit Care Med 1996; 24: 981-4.
2. WILLIAMS FM, CHINN S, HUGHES GR, LEACH RM. Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis 2002; 61: 414-21.
3. HSU CL, CHEN KY, YEH PS et al. Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study. Crit Care 2005; 9: R177-183.
4. ALZEER AH, AL-ARFAJ A, BASHA SJ et al. Outcome of patients with systemic lupus erythematosus in intensive care unit. Lupus 2004; 13: 537-42.
5. WHITELAW DA, GOPAL R, FREEMAN V. Survival of patients with SLE admitted to an intensive care unit-a retrospective study. Clin Rheumatol 2005; 24: 223-7.
6. KHAN SA, SUBLA MR, BEHL D, SPECKS U, AFESSA B. Outcome of patients with smallvessel vasculitis admitted to a medical ICU. Chest 2007; 131: 972-6.
7. CRUZ BA, RAMANOELINA J, MAHR A et al. Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit. Rheumatology 2003; 42: 1183-8.
8. SHALEV T, HAVIV Y, SEGAL E et al. Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases. Clin Exp Rheumatol 2006; 24: 380-6.
9. SHERER Y, SHEPSHELOVICH D, SHALEV T et al. Outcome of patients having dermatomyositis admitted to the intensive care unit. Clin Rheumatol 2007; 26: 1851-5.
10. CAMARGO JF, TOBON GJ, FONSECA N et al. Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus 2005; 14: 315-20.
11. MOREELS M, MELOT C, LEEMAN M. Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med 2005; 31: 591-3.
12. OZBALKAN Z, TOPELI A, KIRAZ S, OZTURK MA, ERTENLI I, CALGUNERI M. The contribution of underlying systemic rheumatic diseases to the mortality in patients admitted for intensive care: a matched cohort study. Clin Exp Rheumatol 2004; 22: 223-6.
13. POURRAT O, BUREAU JM, HIRA M, MARTINBARBAZ F, DESCAMPS JM, ROBERT R. Outcome of patients with systemic rheumatic diseases admitted to intensive care units: a retrospective study of 39 cases. Rev Med Interne 2000; 21: 147-51.
14. KOLLEF MH, ENZENAUER RJ. Predicting outcome from intensive care for patients with rheumatologic diseases. J Rheumatol 1992; 19: 1260-2.
15. GODEAU B, MORTIER E, ROY PM et al. Short and longterm outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol 1997; 24: 1317-23.
16. GODEAU B, BOUDJADJA A, DHAINAUT JF et al. Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis 1992; 51: 627-31.
17. HOCHBERG MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
18. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE AMERICAN RHEUMATISM ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
19. JENNETTE JC, FALK RJ, ANDRASSY K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
20. DALAKAS MC. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Op Pharmacol 2010; 10: 346-52.
21. SCHMIDT J, DALAKAS MC. Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies. Expert Op Med Diagn 2010; 4: 241-50.
22. MIYAKIS S, LOCKSHIN MD, ATSUMI T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
23. GARNER JS, JARVIS WR, EMORI TG, HORAN TC, HUGHES JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-40.
24. ASHERSON RA, CERVERA R, DE GROOT PG et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 530-534.
25. LEVY MM, FINK MP, MARSHALL JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
26. KNAUS WA, DRAPER EA, WAGNER DP, ZIMMERMAN JE. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-29.
27. CERVERA R, TEKTONIDOU MG, ESPINOSA G et al. Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (II): Thrombocytopenia and skin manifestations. Lupus 2011; 20: 174-81.
28. ÑAMEDYS-SILVA SA, BALTAZAR-TORRES JA, RIVERO-SIGARROA E, FONSECA-LAZCANO JA, MONTIEL-LÓPEZ L, DOMÍNGUEZCHERIT G. Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit. Lupus 2009; 18: 1252-8.
29. BROCHARD L, ABROUG F, BRENNER M et al. ATS/ERS/ESICM/SCCM/SRLF Ad Hoc Committee on Acute Renal Failure. An official ATS/ERS/ESICM/SCCM/SRLF statement: prevention and management of acute renal failure in the ICU patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med 2010; 181: 1128-55.